Osaka, Japan

Masatoshi Minagawa


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Masatoshi Minagawa

Introduction

Masatoshi Minagawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazine and beta-alanine derivatives. With a total of three patents to his name, Minagawa's inventions have the potential to impact various therapeutic applications.

Latest Patents

Minagawa's latest patents include "Pyrazine derivatives and pharmaceutical use thereof," which focuses on a specific pyrazine derivative formula. Another significant patent is "Beta-alanine derivatives and their use as receptor antagonists," detailing a beta-alanine derivative with various substituents that enhance its pharmaceutical properties. These patents reflect his commitment to advancing medical science through innovative chemical compounds.

Career Highlights

Throughout his career, Minagawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH, where he has contributed to the development of new therapeutic agents. His work has been instrumental in pushing the boundaries of pharmaceutical research.

Collaborations

Minagawa has collaborated with esteemed colleagues such as Atsushi Akahane and Kohei Takenaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Masatoshi Minagawa's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…